Cargando…
A continuous (13)C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT
Up to 30% of patients with hepatitis C virus (HCV) infection and normal serum alanine aminotransferase (NALT) have significant liver disease. Currently, many of these patients undergo a liver biopsy to guide therapeutic decisions. The BreathID® continuous online (13)C-methacetin breath test (MBT) re...
Autores principales: | Lalazar, G, Pappo, O, Hershcovici, T, Hadjaj, T, Shubi, M, Ohana, H, Hemed, N, Ilan, Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2658713/ https://www.ncbi.nlm.nih.gov/pubmed/18638013 http://dx.doi.org/10.1111/j.1365-2893.2008.01007.x |
Ejemplares similares
-
Role of (13)C methacetin breath test for non invasive staging of liver fibrosis in patients with chronic hepatitis C
por: Fierbinteanu-Braticevici, Carmen, et al.
Publicado: (2014) -
Diagnostic Value of the (13)C Methacetin Breath Test in Various Stages of Chronic Liver Disease
por: Razlan, Hamizah, et al.
Publicado: (2011) -
Assessment of Hepatic Detoxification Activity: Proposal of an Improved Variant of the (13)C-Methacetin Breath Test
por: Holzhütter, Hermann-Georg, et al.
Publicado: (2013) -
(13)C Methacetin Breath Test for Assessment of Microsomal Liver Function: Methodology and Clinical Application
por: Gorowska-Kowolik, Katarzyna, et al.
Publicado: (2017) -
(13)C-Methacetin Breath Test Predicts Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Gairing, Simon Johannes, et al.
Publicado: (2022)